Smruthi Organics Limited

BSE: SMRUTHIORG540686ISIN INE172E01011

Healthcare
Pharmaceuticals

Share price

₹140.30-1.80 (-1.27%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹175.30
52W low: ₹95.00
Off 52W high: -19.97%
1M return: -10.41%
3M return: +17.26%
6M return: +17.41%
1Y return: +7.92%
20D avg volume: 2,751
50 DMA: ₹148.49
200 DMA: ₹124.45

Key ratios Standalone

Market cap: ₹160.59 Cr
Current price: ₹140.30
52W high / low: ₹175.30 / ₹95.00
Face value: ₹10.00
P/E: 21.72
P/B: 2.37
EPS (TTM): ₹6.46
Book value / share: ₹59.20
ROE: 10.92%
ROCE: 8.20%
Operating margin: 19.94%
Net margin: 9.82%
Debt / equity: 0.11
Net debt: ₹6.65 Cr
Interest cover: 3.77
Dividend yield: 1.07%
Dividend / share (TTM): ₹1.50
Payout: 23.22%
Cash conversion cycle: 121.3 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	29.30	29.09	22.29	31.60	18.99	38.09	31.25	29.39	27.27	—
	0.03	0.02	0.01	0.01	0.09	0.08	0.00	0.01	0.00	—
	29.33	29.11	22.30	31.61	19.08	38.17	31.25	29.40	27.27	—
	25.40	27.36	20.22	28.76	20.63	35.44	28.96	28.27	28.53	—
	13.92	12.12	10.02	11.08	12.01	19.36	15.50	15.16	17.84	—
	0.00	0.00	0.00	0.00	0.03	0.03	0.02	0.03	0.06	—
	4.49	4.49	4.54	4.30	4.23	4.15	4.43	5.12	3.65	—
	0.31	0.31	0.25	0.66	0.46	0.52	0.51	0.44	0.41	—
	1.60	1.75	1.67	1.51	1.41	1.50	1.37	1.33	1.29	—
	5.85	6.39	7.13	6.87	5.63	6.96	7.73	6.13	7.05	—
	3.93	1.75	2.08	2.85	-1.55	2.73	2.29	1.13	-1.25	—
	0.00	-0.01	-0.45	0.00	0.00	0.00	—	—	—	—
	3.93	1.74	1.63	2.85	-1.55	2.73	2.29	1.13	-1.25	—
	0.98	0.67	0.23	0.79	0.46	0.51	0.81	0.36	0.33	—
	2.88	1.07	1.40	2.06	-1.10	2.23	1.48	0.78	-0.92	—
	2.57	0.93	1.22	1.80	-0.96	1.95	1.29	0.68	-0.81	—
Key metrics
	5.84	3.80	3.55	5.02	0.32	4.75	4.17	2.90	0.45	—
	19.90%	13.10%	15.90%	15.90%	1.70%	12.50%	13.30%	9.90%	1.70%	—
	9.80%	3.70%	6.30%	6.50%	-5.80%	5.90%	4.70%	2.70%	-3.40%	—
	—	2.70%	—	4.50%	—	4.00%	—	—	—	—
	54.30%	-23.60%	-28.70%	7.50%	-30.40%	—	—	—	—	—
	361.80%	-52.00%	-5.40%	164.10%	-19.60%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	112.28	101.97	126.01	—
	0.07	0.12	0.09	—
	112.35	102.09	126.10	—
	101.74	96.96	121.20	—
	47.14	45.23	67.86	—
	0.00	0.03	0.14	—
	17.82	17.56	17.35	—
	1.53	1.68	1.87	—
	6.53	6.35	5.50	—
	26.24	26.02	27.87	—
	10.61	5.13	4.90	—
	-0.46	-0.46	0.00	—
	10.15	4.66	4.90	—
	2.67	1.24	1.34	—
	7.41	3.43	3.56	—
	6.52	2.99	3.11	—
Key metrics
	18.21	12.69	12.27	—
	16.22%	12.40%	9.70%	—
	6.60%	3.40%	2.80%	—
	—	8.20%	8.40%	—
	-4.62%	-19.10%	—	—
	118.58%	-3.70%	—	—
	—	13.79	-1.54	—
	—	6.49	2.80	—
	—	0.11	0.23	—
	—	6.65	16.36	—
	—	121.3	129.8	—
Balance sheet
	—	103.55	111.74	—
	—	52.68	63.33	—
	—	1.71	0.44	—
	—	19.30	32.47	—
	—	28.35	28.31	—
	—	2.75	1.92	—
	—	46.52	44.67	—
	—	13.77	15.99	—
	—	26.56	31.08	—
	—	8.36	16.80	—
	—	5.69	8.67	—
	—	2.67	8.13	—
	—	73.51	71.63	—
Cash flow
	—	22.26	9.98	—
	—	-8.92	-11.42	—
	—	-12.07	1.40	—
	—	8.47	11.52	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -4.62%
Profit YoY (TTM): +118.58%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 64.72%

Quarter	September 2026	June 2026
Promoter %	64.72%	64.72%

Holder	Type	Holding	Previous	Change
EAGA PURUSHOTHAM MALAIAH	Promoter	41.23%	41.23%	0.00%
VAISHNAVI PURUSHOTHAM EAGA	Promoter Group	15.27%	15.27%	0.00%
SWAPNIL PURUSHOTHAM EAGA	Promoter Group	5.24%	5.24%	0.00%
SMRUTHI CHEMICALS AND INTERMEDIATES LLP	Promoter Group	2.15%	2.15%	0.00%
SMRUTHI PURUSHOTHAM EAGA	Promoter Group	0.78%	0.78%	0.00%
YADAGIRI M EGA	Promoter Group	0.05%	0.05%	0.00%
EAGA RAJAMOULI	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Smruthi Organics Limited S	161	140.30	21.72	8.20%	-4.62% TTM	+118.58% TTM	+7.92%

Filings & corporate actions

Recent announcements

Smruthi Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Prior Intimation of Board ....4 Nov 2026 · Board Meeting / Board Meeting
Intimation regarding receipt of ANVISA Inspection Report21 Oct 2026 · Company Update / General
Approval from CG for appointment of Ms SmruthI eaga as Whoel Time Director7 Oct 2026 · Company Update / General
Compliance Certificate6 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Notice of Closure of Trading Window29 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper Publication - Financial Results11 Aug 2026 · Company Update / Newspaper Publication
Scrutinisers Report and Voting Results of AGM10 Aug 2026 · AGM/EGM / AGM
Outcome of 37th Annual General Meeting held today i.e 10th August 202610 Aug 2026 · AGM/EGM / AGM
Un Audited Quarterly Results of the Company for the first quarter ended 30th June 202610 Aug 2026 · Board Meeting / Outcome of Board Meeting
Un Audited Financial Results of the Company for the first quarter ended 30.06.202610 Aug 2026 · Result / Financial Results
Smruthi Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Approve and take on record ....30 Jul 2026 · Board Meeting / Board Meeting
Newspaper Publication- Post dispatch of Annual Report21 Jul 2026 · Company Update / Newspaper Publication
Notice of 37th Annual General Meeting of Smruthi Organics Ltd17 Jul 2026 · AGM/EGM / AGM
Annual Report of FY 2025-202617 Jul 2026 · Others / Reg. 34 (1) Annual Report
Newspaper Publication of Notice of 37th AGM of the Company16 Jul 2026 · Company Update / Newspaper Publication
Compliance Certificate13 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Notice of Closure of Trading Window29 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper Advertisement- Financial Results15 May 2026 · Company Update / Newspaper Publication
Intimation of Record Date14 May 2026 · Corp. Action / Record Date
Annual Secretarial Compliance Report for the financial year ended 31st March 202614 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
AGM Intimation13 May 2026 · AGM/EGM / AGM
Record Date13 May 2026 · Corp. Action / Record Date
Book Closure for AGM and Dividend13 May 2026 · Corp. Action / Book Closure
Board approves Dividend13 May 2026 · Corp. Action / Dividend
Change in management13 May 2026 · Company Update / Change in Management
Audited Financial Results for the quarter and financial year ended 31st March 202613 May 2026 · Result / Financial Results
Outcome of Board meeting of the Company held today i.e 13th May 202613 May 2026 · Board Meeting / Outcome of Board Meeting
Smruthi Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve Audited Financial Statements ....6 May 2026 · Board Meeting / Board Meeting
Clarification letter27 Apr 2026 · Company Update / General
Compliance Certificate- Reg 74(5)7 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate- Regulation 74(5)7 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Notice of Closure of Trading window30 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
We are pleased to inform that the Company has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & Helathcare (EDQM), Europe for its ....9 Mar 2026 · Company Update / General
Receipt of "Attestation of Inspection" from EDQM4 Mar 2026 · Company Update / General
Newspaper Advertisement- Financial Results16 Feb 2026 · Company Update / Newspaper Publication
Financial Results13 Feb 2026 · Result / Financial Results
Outcome of board meeting held on Friday, 13th February 202613 Feb 2026 · Board Meeting / Outcome of Board Meeting
Smruthi Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) ....5 Feb 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of SEBi (DP) Regulations 2018 for quarter ended 31st December, 2025.7 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window29 Dec 2025 · Insider Trading / SAST / Closure of Trading Window

Corporate actions

Purpose	Ex date	Record date	Payment date
Dividend - Rs. - 1.5000	31 Jul 2026	31 Jul 2026	—
Final Dividend - Rs. - 1.5000	13 Jun 2025	13 Jun 2025	—
Final Dividend - Rs. - 1.5000	6 Sep 2024	—	—

Board meetings

10 Aug 2026 Board Meeting - Financial Results